Sol-Gel Delivery
Revolutionizing Drug Delivery to the Brain
The Sol-Gel platform is an adaptable water-based formulation that uses exclusively FDA-approved excipients. It allows for controlled and sustained drug delivery. This innovative system can deliver therapeutics directly to the brain by bypassing the blood-brain barrier, thus enhancing bioavailability and reducing side effects.
Next steps
PreveCeutical now plans to begin exploratory discussions with pharmaceutical and biotechnology companies developing therapies for neurological disorders, that are seeking a targeted nose-to-brain drug delivery system in connection with same, with the intention of forming a partnership for the co-development of PreveCeutical's soluble gel.
"Sol-gel technology has certainly shown significant promise in laboratory testing at this point. eventually, I would like to see this proprietary technology be successfully applied to a drug which could be targeted for CNS delivery at the right time, we would welcome an opportunity to work with a pharmaceutical or biotechnology company to co-develop the Sol-Gel and sol-gel Applicator to be used in pharmaceutical and therapeutic products." – Chief Science Officer: Dr. Mak Jawadekar, PhD.